• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共聚焦显微镜分析天然、全长及B结构域缺失的凝血因子VIII在哺乳动物细胞中的运输。

Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells.

作者信息

Becker Sven, Simpson Jeremy C, Pepperkok Rainer, Heinz Stefan, Herder Christian, Grez Manuel, Seifried Erhard, Tonn Torsten

机构信息

Institute for Transfusion Medicine and Immunohematology, Red Cross Blood Donor Service Baden-Wuerttemberg-Hesse, Sandhofstr. 1, D-60528 Frankfurt, Germany.

出版信息

Thromb Haemost. 2004 Jul;92(1):23-35. doi: 10.1160/TH03-06-0360.

DOI:10.1160/TH03-06-0360
PMID:15213841
Abstract

In mammalian cells, factor VIII (FVIII) secretion depends upon its interaction with chaperones of the endoplasmic reticulum (ER) and requires a unique ATP-dependent step to dissociate aggregates formed within the ER. To further elucidate mechanisms which might account for the inefficient secretion of recombinant FVIII (rFVIII), we have analyzed the pathways of recombinant full length (rFVIII-FL) and B-domain deleted (rFVIII Delta B) FVIII and compared these to the secretion route of native FVIII in primary hepatocytes. Using confocal laser scanning microscopy in combination with a pulse chase of a known secretion marker, we describe the trafficking route of FVIII, which upon release from the ER--where it colocalizes with calnexin--is transported to the Golgi complex in vesicular-tubular transport complexes (VTCs) which could be further identified as being COP I coated. However, a large portion of rFVIII is retained in the ER and additionally in structures which could not be assigned to the ER, Golgi complex or intermediate compartment. Moderate BiP transcription levels indicate that this observed retention of FVIII does not reflect cellular stress due to an overexpression of FVIII-protein in transduced cells. Moreover, a pulse of newly synthesized rFVIII protein is released within 4 hrs, indicating that once rFVIII is released from the ER there is no further limitation to its secretion. Our data provide new details about the secretory route of FVIII, which may ultimately help to identify factors currently limiting the efficient and physiological expression of FVIII in gene therapy and manufacture.

摘要

在哺乳动物细胞中,凝血因子VIII(FVIII)的分泌依赖于它与内质网(ER)伴侣蛋白的相互作用,并且需要一个独特的ATP依赖步骤来解离在内质网中形成的聚集体。为了进一步阐明可能解释重组FVIII(rFVIII)分泌效率低下的机制,我们分析了重组全长(rFVIII-FL)和B结构域缺失(rFVIII ΔB)FVIII的途径,并将这些与原代肝细胞中天然FVIII的分泌途径进行了比较。使用共聚焦激光扫描显微镜结合已知分泌标记物的脉冲追踪,我们描述了FVIII的运输途径,FVIII从与钙连接蛋白共定位的内质网释放后,通过囊泡管状运输复合体(VTCs)被运输到高尔基体复合体,这些复合体可进一步鉴定为被COP I包被。然而,大部分rFVIII保留在内质网中,此外还保留在无法归属于内质网、高尔基体复合体或中间区室的结构中。适度的BiP转录水平表明,观察到的FVIII保留并不反映由于转导细胞中FVIII蛋白过表达导致的细胞应激。此外,新合成的rFVIII蛋白在4小时内释放,这表明一旦rFVIII从内质网释放,其分泌就不再有进一步的限制。我们的数据提供了关于FVIII分泌途径的新细节,这最终可能有助于识别目前在基因治疗和生产中限制FVIII高效和生理性表达的因素。

相似文献

1
Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells.共聚焦显微镜分析天然、全长及B结构域缺失的凝血因子VIII在哺乳动物细胞中的运输。
Thromb Haemost. 2004 Jul;92(1):23-35. doi: 10.1160/TH03-06-0360.
2
Factor VIII-eGFP fusion proteins with preserved functional activity for the analysis of the early secretory pathway of factor VIII.具有保留功能活性的 VIII 因子-eGFP 融合蛋白,用于分析 VIII 因子的早期分泌途径。
Thromb Haemost. 2009 Nov;102(5):925-35. doi: 10.1160/TH08-12-0807.
3
Biosynthesis, assembly and secretion of coagulation factor VIII.凝血因子 VIII 的生物合成、组装与分泌。
Blood Coagul Fibrinolysis. 1997 Dec;8 Suppl 2:S3-14.
4
How Full-Length FVIII Benefits from Its Heterogeneity - Insights into the Role of the B-Domain.全长 FVIII 如何受益于其异质性 - B 结构域作用的见解。
Pharm Res. 2019 Apr 1;36(5):77. doi: 10.1007/s11095-019-2599-2.
5
Blood coagulation factor VIII D1241E polymorphism leads to a weak malectin interaction and reduction of factor VIII posttranslational modification and secretion.凝血因子VIII D1241E多态性导致与麦芽凝集素的相互作用减弱,并降低凝血因子VIII的翻译后修饰和分泌。
Exp Cell Res. 2020 Dec 1;397(1):112334. doi: 10.1016/j.yexcr.2020.112334. Epub 2020 Nov 2.
6
In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile.在体研究显示,重组凝血因子 VIII 制剂在蛋白含量、活性和凝血酶激活谱方面存在显著差异。
Haemophilia. 2013 May;19(3):392-8. doi: 10.1111/hae.12076. Epub 2012 Dec 18.
7
Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins.重组弗林蛋白酶对重组人凝血因子VIII B结构域变体的蛋白水解加工增强
Mol Biotechnol. 2016 Jun;58(6):404-14. doi: 10.1007/s12033-016-9939-9.
8
Cell surface staining of recombinant factor VIII is reduced in apoptosis resistant BHK-21 cells.在抗凋亡的BHK-21细胞中,重组凝血因子VIII的细胞表面染色减少。
J Biotechnol. 2008 Oct 10;137(1-4):20-7. doi: 10.1016/j.jbiotec.2008.07.1856. Epub 2008 Jul 25.
9
Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A.化学伴侣改善了血友病 A 模型小鼠的蛋白分泌,并挽救了突变型因子 VIII。
PLoS One. 2012;7(9):e44505. doi: 10.1371/journal.pone.0044505. Epub 2012 Sep 4.
10
Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum.VIII 因子在内质网中表现出伴侣依赖性和葡萄糖调节的可逆淀粉样形成。
Blood. 2020 May 21;135(21):1899-1911. doi: 10.1182/blood.2019002867.

引用本文的文献

1
Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A.血友病 A 的 AAV 基因转移后多年的因子 VIII 表达。
N Engl J Med. 2021 Nov 18;385(21):1961-1973. doi: 10.1056/NEJMoa2104205.
2
Flow-Cytometry Platform for Intracellular Detection of FVIII in Blood Cells: A New Tool to Assess Gene Therapy Efficiency for Hemophilia A.用于血细胞内FVIII检测的流式细胞术平台:评估A型血友病基因治疗效率的新工具。
Mol Ther Methods Clin Dev. 2019 Nov 15;17:1-12. doi: 10.1016/j.omtm.2019.11.003. eCollection 2020 Jun 12.
3
Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy.
用于血友病基因治疗的蛋白质工程凝血因子
Mol Ther Methods Clin Dev. 2018 Dec 31;12:184-201. doi: 10.1016/j.omtm.2018.12.007. eCollection 2019 Mar 15.
4
Production of recombinant coagulation factors: Are humans the best host cells?重组凝血因子的生产:人类细胞是最佳宿主细胞吗?
Bioengineered. 2017 Sep 3;8(5):462-470. doi: 10.1080/21655979.2017.1279767. Epub 2017 Feb 23.
5
The F309S mutation increases factor VIII secretion in human cell line.F309S突变增加人细胞系中凝血因子VIII的分泌。
Rev Bras Hematol Hemoter. 2016 Apr-Jun;38(2):135-40. doi: 10.1016/j.bjhh.2016.04.002. Epub 2016 Apr 20.
6
Comparison of human coagulation factor VIII expression directed by cytomegalovirus and mammary gland-specific promoters in HC11 cells and transgenic mice.巨细胞病毒和乳腺特异性启动子在HC11细胞及转基因小鼠中指导人凝血因子VIII表达的比较
Blood Coagul Fibrinolysis. 2015 Oct;26(7):755-61. doi: 10.1097/MBC.0000000000000318.
7
Gene therapy for hemophilia.血友病的基因治疗。
Front Biosci (Landmark Ed). 2015 Jan 1;20(3):556-603. doi: 10.2741/4324.
8
Quantitative correlation between transcriptional levels of ER chaperone, peroximal protein and FVIII productivity in human Hek-293 cell line.人Hek - 293细胞系中雌激素受体伴侣、过氧化物酶体蛋白转录水平与凝血因子VIII产量之间的定量相关性。
Springerplus. 2013 Jul 18;2(1):328. doi: 10.1186/2193-1801-2-328. eCollection 2013.
9
Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A.化学伴侣改善了血友病 A 模型小鼠的蛋白分泌,并挽救了突变型因子 VIII。
PLoS One. 2012;7(9):e44505. doi: 10.1371/journal.pone.0044505. Epub 2012 Sep 4.
10
Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional protein.因子 VIII A3 结构域置换 N1922S 导致特异性结构域错误折叠和功能性蛋白低分泌的血友病 A。
Blood. 2011 Mar 17;117(11):3190-8. doi: 10.1182/blood-2010-09-307074. Epub 2011 Jan 7.